Literature DB >> 3027175

Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.

R Cauda, C E Grossi, R J Whitley, A B Tilden.   

Abstract

We sought to identify imbalances of immune regulatory cells that might contribute to the depression of cell-mediated immunity that occurs during an episode of herpes zoster. Peripheral blood mononuclear cells (PBMC) were obtained from patients with herpes zoster during the acute (less than 7 days after disease onset) and convalescent (more than 10 days after disease onset) phases of illness and from healthy seropositive donors. The PBMC were analyzed for: lymphoproliferative responses to varicella-zoster virus (VZV) antigens, Leu-3 (helper/inducer):Leu-2 (cytotoxic/suppressor) ratios, and percentages of suppressor cells as defined by coexpression of the Leu-2 and OKM1 antigens. Significantly depressed proliferative responses of VZV antigens and Leu-3:Leu-2 ratios, and increased percentages of Leu-2+ OKM1+ suppressor cells were observed in PBMC of acute phase herpes zoster patients as compared with the PBMC of convalescent patients or healthy donors. These differences were also observed in individual patients sequentially studied during both phases of disease. Cryopreserved acute phase PBMC suppressed the proliferative response of autologous convalescent phase PBMC to VZV antigens, but not to herpes simplex virus (HSV) antigens. The acute phase PBMC suppressor cell was radiation sensitive and was identified as a Leu-2+ cell by fluorescence-activated cell sorting. Thus, depression of cell-mediated immunity during the acute phase of herpes zoster was associated with a relative increase of lymphocytes expressing a suppressor cell phenotype and the activation of a radiosensitive Leu-2+ suppressor cell with some degree of antigen specificity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.

Authors:  Sheng-mei Zhu; Yong-min Liu; Er-dan An; Qing-lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-08       Impact factor: 3.066

2.  Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

Authors:  J W Gratama; R A Langelaar; M A Oosterveer; J A van der Linden; A den Ouden-Noordermeer; A M Naipal; J W Visser; G C de Gast; H J Tanke
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Immunosuppression in experimental cryptococcosis in rats. Induction of efferent T suppressor cells to a non-related antigen.

Authors:  D T Masih; C E Sotomayor; H R Rubinstein; C M Riera
Journal:  Mycopathologia       Date:  1991-06       Impact factor: 2.574

4.  Remission of rheumatoid arthritis after acute disseminated varicella-zoster infection.

Authors:  Vikas Agarwal; Ram Singh; Sandeep Chauhan
Journal:  Clin Rheumatol       Date:  2006-01-21       Impact factor: 3.650

5.  The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.

Authors:  A N Akbar; N Borthwick; M Salmon; W Gombert; M Bofill; N Shamsadeen; D Pilling; S Pett; J E Grundy; G Janossy
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.

Authors:  Mathieu Nacher; Celia Basurko; Antoine Adenis; Emilie Gaubert-Marechal; Emilie Mosnier; Sophie Edouard; Vincent Vantilcke; Sindou Sivapregassam; Benoit Tressières; André Cabié; Pierre Couppié
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.